Top compounds associated with response to CCNI


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.18 0.0004
mRNA NG-25 GDSC1000 pan-cancer AAC 0.11 0.0005
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.12 0.0009
Download CSV